Core Viewpoint - Beisen Holdings (09669) anticipates significant revenue growth and a reduction in losses for the six months ending September 30, 2025, driven by increased income and decreased share-based payment expenses [1] Financial Performance - Projected revenue for the six months ending September 30, 2025, is expected to be between approximately RMB 503.1 million and RMB 526.3 million, representing a growth of about 15.2% to 20.5% [1] - Expected annual recurring revenue for the same period is projected to be between approximately RMB 946.7 million and RMB 975.4 million, with an increase of about 20.8% to 24.4% [1] - Subscription revenue retention rate is anticipated to be around 104% to 106% [1] Loss Reduction - The company expects a loss attributable to owners for the six months ending September 30, 2025, to be between approximately RMB 14.6 million and RMB 23.8 million, reflecting a decrease in losses of about 76.0% to 85.2% [1] - The reduction in losses is primarily due to a decrease in share-based payment expenses by approximately RMB 27.8 million to RMB 30.7 million compared to the same period in 2024, along with the aforementioned revenue growth [1] Adjusted Profit - After excluding share-based payments, acquisition-related intangible asset amortization, and related tax impacts (all non-cash and non-operating), the company anticipates an adjusted net profit (non-IFRS measure) for the six months ending September 30, 2025, to be between approximately RMB 13.8 million and RMB 23.6 million, compared to an adjusted net loss of approximately RMB 34.2 million in the same period of 2024 [1]

Core Viewpoint - Beisen Holdings (09669) anticipates significant revenue growth and a reduction in losses for the six months ending September 30, 2025, indicating a positive outlook for the company's financial performance [1] Financial Performance Summary - The expected revenue for the six months ending September 30, 2025, is projected to be between approximately RMB 503.1 million and RMB 526.3 million, representing an increase of about 15.2% to 20.5% [1] - The anticipated annual recurring revenue for the same period is expected to range from approximately RMB 946.7 million to RMB 975.4 million, reflecting a growth of about 20.8% to 24.4% [1] - The subscription revenue retention rate is projected to be around 104% to 106% for the six months ending September 30, 2025 [1] Loss Reduction Summary - The company expects a loss attributable to owners of approximately RMB 14.6 million to RMB 23.8 million, which represents a decrease of about 76.0% to 85.2% compared to previous periods [1] - The reduction in losses is primarily due to a decrease in share-based payments by approximately RMB 27.8 million to RMB 30.7 million compared to the same period in 2024, along with the aforementioned revenue growth [1] - After excluding share-based payments, acquisition-related intangible asset amortization, and related tax impacts, the adjusted net profit (non-IFRS measure) is expected to be between approximately RMB 13.8 million and RMB 23.6 million, compared to an adjusted net loss of approximately RMB 34.2 million in the same period of 2024 [1]

（於開曼群島註冊成立的有限公司） Beisen Holding Limited （股份代號：9669） 正面盈利預告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任 何 損 失 承 擔 任 何 責 任。 本公司仍在落實本集團截至2025年9月30日 止 六 個 月 的 中 期 業 績。本 公 告所載資料僅為董事會參考未經審核綜合管理賬目及目前所得資料所 作 的 初 步 評 估，該 等 資 料 尚 未 經 本 公 司 核 數 師 及 審 核 委 員 會 審 核 或 審 閱，須 在 必 要 時 進 行 調 整。本 公 司 股 東 及 潛 在 投 資 者 務 請 仔 細 閱 讀 預 期 將 於2025年11月底前刊發的本公司截至2025年9月30日止六個月的中期 業 績 公 告。上 述 中 期 業 績 公 告 中 的 資 料 與 上 文 所 載 的 估 計 財 務 資 料 可 能 存 在 差 異。 本 公 司 股 東 及 潛 ...

Core Viewpoint - Multiple companies in China conducted share buybacks on October 20, 2025, with notable activity from Mengniu Dairy, which had the largest buyback amount of 10.14 million yuan for 700,000 shares [1][2] Summary by Company - **Mengniu Dairy (02319)**: - Buyback of 700,000 shares - Total buyback amount of 10.14 million yuan - Year-to-date cumulative buyback of 1.92 million shares, representing 0.491% of total share capital [2] - **YunGongChang (N23027)**: - Buyback of 1.87 million shares - Total buyback amount of 7.53 million yuan - Year-to-date cumulative buyback of 2.45 million shares, representing 5.33% of total share capital [2] - **Lianyi Rong Technology (09959)**: - Buyback of 2.45 million shares - Total buyback amount of 7.44 million yuan - Year-to-date cumulative buyback of 6.54 million shares, representing 3.06% of total share capital [2] - **Guoshengtang (02273)**: - Buyback of 232,000 shares - Total buyback amount of 6.83 million yuan - Year-to-date cumulative buyback of 467,810 shares, representing 1.97% of total share capital [2] - **Antong Oilfield Services (03337)**: - Buyback of 4.42 million shares - Total buyback amount of 4.94 million yuan - Year-to-date cumulative buyback of 3.37 million shares, representing 1.14% of total share capital [2] - **Weishi Jiajie (00856)**: - Buyback of 500,000 shares - Total buyback amount of 4.53 million yuan - Year-to-date cumulative buyback of 663,800 shares, representing 0.462% of total share capital [2] - **Beisen Holdings (09669)**: - Buyback of 400,600 shares - Total buyback amount of 3.24 million yuan - Year-to-date cumulative buyback of 143,260 shares, representing 0.204% of total share capital [2] - **Zhongxu Future (09890)**: - Buyback of 228,200 shares - Total buyback amount of 3.13 million yuan - Year-to-date cumulative buyback of 598,580 shares, representing 1.12% of total share capital [2] - **Shoujia Technology (00103)**: - Buyback of 2.8 million shares - Total buyback amount of 2.21 million yuan - Year-to-date cumulative buyback of 5.75 million shares, representing 2.45% of total share capital [2] - **Meili Tianyuan Medical Health (02373)**: - Buyback of 70,000 shares - Total buyback amount of 2.21 million yuan - Year-to-date cumulative buyback of 30,050 shares, representing 0.127% of total share capital [2] - **Kangchen Pharmaceutical (01681)**: - Buyback of 100,000 shares - Total buyback amount of 1.54 million yuan - Year-to-date cumulative buyback of 623,200 shares, representing 7.32% of total share capital [2]

| 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.10.20 | 40.06 | 8.090 | 8.020 | 323.92 | | 2025.10.17 | 30.00 | 8.090 | 7.870 | 240.72 | | 2025.10.16 | 18.00 | 8.170 | 7.970 | 144.87 | | 2025.10.15 | 30.68 | 8.250 | 8.120 | 252.91 | | 2025.09.29 | 24.52 | 8.200 | 8.050 | 200.70 | | 2025.09.08 | 40.50 | 8.000 | 7.930 | 323.24 | | 2025.09.04 | 42.46 | 7.950 | 7.810 | 335.90 | | 2025.08.29 | 19.92 | 8.110 | 7.940 | 161.36 | | 2025.08.28 | 20.00 | 8.050 | 7.900 | 159 ...

Core Viewpoint - Beisen Holdings (09669.HK) announced a share buyback plan, intending to repurchase 400,000 shares at a cost of HKD 3.24 million on October 20 [1] Group 1 - The company will spend HKD 3.24 million for the buyback [1] - The buyback involves acquiring 400,000 shares [1]

北森控股(09669)发布公告，于2025年10月20日，斥资323.9万港元回购40.06万股;根据首次公开发售前购 股权计划发行2.3万股。 ...

智通财经APP讯，北森控股(09669)发布公告，于2025年10月20日，斥资323.9万港元回购40.06万股; 根 据首次公开发售前购股权计划发行2.3万股。 ...

FF305 | | | 第 2 頁 共 7 頁 v 1.3.0 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 北森控股有限公司 呈交日期： 2025年10月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 09669 | 說明 | 股份 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變 ...

Summary of Key Points Core Viewpoint - On October 17, 42 Hong Kong-listed companies conducted share buybacks, totaling 46.36 million shares and an aggregate amount of HKD 621 million [1][2]. Company-Specific Summaries - **Xiaomi Group-W**: - Repurchased 10.70 million shares for HKD 494 million, with a highest price of HKD 46.760 and a lowest price of HKD 45.900. The total buyback amount for the year reached HKD 1.537 billion [1][2]. - **Sihuan Pharmaceutical**: - Repurchased 15 million shares for HKD 21.76 million, with a highest price of HKD 1.470 and a lowest price of HKD 1.430. The total buyback amount for the year reached HKD 143.32 million [1][2]. - **Mengniu Dairy**: - Repurchased 1.20 million shares for HKD 16.97 million, with a highest price of HKD 14.250 and a lowest price of HKD 14.070. The total buyback amount for the year reached HKD 433.54 million [1][2]. - **AAC Technologies**: - Repurchased 300,000 shares for HKD 11.60 million, with a highest price of HKD 38.800 and a lowest price of HKD 38.480. The total buyback amount for the year reached HKD 84.64 million [1][2]. - **Vitasoy International**: - Repurchased 1.02 million shares for HKD 8.20 million, with a highest price of HKD 8.040 and a lowest price of HKD 8.020. The total buyback amount for the year reached HKD 27.54 million [1][2]. Overall Market Activity - The highest buyback amount on October 17 was from Xiaomi Group-W at HKD 494 million, followed by Sihuan Pharmaceutical at HKD 21.76 million. Other notable companies included Mengniu Dairy and AAC Technologies [1][2]. - In terms of share quantity, Sihuan Pharmaceutical led with 15 million shares repurchased, followed by Xiaomi Group-W with 10.70 million shares and Anton Oilfield Services with 4.49 million shares [1][2].